Ibrutinib in relapsed chronic lymphocytic leukemia

N Engl J Med. 2013 Sep 26;369(13):1278-9. doi: 10.1056/NEJMc1309710.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrazoles / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Pyrazoles
  • Pyrimidines
  • Protein-Tyrosine Kinases